Optimal Arrangement of Four Short DNA Strands for Delivery of Immunostimulatory Nucleic Acids to Immune Cells. by Ohtsuki, Shozo et al.
Title Optimal Arrangement of Four Short DNA Strands for Deliveryof Immunostimulatory Nucleic Acids to Immune Cells.
Author(s)
Ohtsuki, Shozo; Matsuzaki, Noriyuki; Mohri, Kohta; Endo,
Masayuki; Emura, Tomoko; Hidaka, Kumi; Sugiyama, Hiroshi;
Takahashi, Yuki; Ishiyama, Kenichi; Kadowaki, Norimitsu;
Takakura, Yoshinobu; Nishikawa, Makiya




Final publication is available from Mary Ann Liebert, Inc.,
publishers http://dx.doi.org/10.1089/nat.2014.0524.; This is not








Optimal Arrangement of Four Short DNA Strands for Delivery of 
Immunostimulatory Nucleic Acids to Immune Cells  
Shozo Ohtsuki1, Noriyuki Matsuzaki1, Kohta Mohri1, Masayuki Endo2, Tomoko Emura3, Kumi Hidaka3, 
Hiroshi Sugiyama2,3, Yuki Takahashi1, Kenichi Ishiyama4, Norimitsu Kadowaki4, Yoshinobu Takakura1 
and Makiya Nishikawa1* 
1 Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical 
Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan 
2 Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, Sakyo-ku, Kyoto 606-8501, 
Japan 
3 Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, 
Japan                                                                                                                                                        
4 Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, 
Kyoto 606-8507, Japan 
* To whom correspondence should be addressed. Tel: +81-75-753-4580; Fax: +81-75-753-4614; 
Email: makiya@pharm.kyoto-u.ac.jp 
Present Address: Kohta Mohri, Laboratory of Drug Delivery System, Faculty of Pharmaceutical 
Sciences, Setsunan University, Hirakata, Osaka 573-0101, Japan  
Norimitsu Kadowaki, Department of Internal Medicine, Division of Hematology, Rheumatology and 
Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan 
 
Short title: DNA arrangement for delivery to immune cells 
 
ABSTRACT 
Nanosized DNA assemblies are useful for delivering immunostimulatory cytosine-phosphate-guanine 
(CpG) DNA to immune cells, but little is known about the optimal structure for such delivery. Here we 
designed three different DNA nanostructures using four 55-mer oligodeoxynucleotides (ODNs), i.e., 
tetrapod-like structured DNA (tetrapodna), tetrahedral DNA (tetrahedron), and tetragonal DNA 
(tetragon), and compared their potencies. Electrophoresis showed that tetrapodna was obtained with 
high yield and purity, whereas tetrahedron formed multimers at high ODN concentrations. Atomic 
force microscopy revealed that all preparations were properly constructed under optimal conditions. 
The thermal stability of tetrapodna was higher than those of the others. Dynamic light scattering 
analysis showed that all of the assemblies were about 8 nm in diameter. Upon addition to mouse 
macrophage-like RAW264.7 cells, tetrahedron was most efficiently taken up by the cells. Then, a CpG 
DNA, a ligand for Toll-like receptor 9, was linked to these DNA nanostructures and added to 
RAW264.7 cells. CpG tetrahedron induced the largest amount of tumor necrosis factor-α, followed by 
CpG tetrapodna. Similar results were obtained using human peripheral blood mononuclear cells. 
Taken together, these results indicate that tetrapodna is the best assembly with the highest yield and 
high immunostimulatory activity, and tetrahedron can be another useful assembly for cellular delivery 




Recent advances in DNA nanotechnology have greatly increased the potential of DNA strands as a 
building block for DNA assemblies (1). A variety of uniquely structured DNA assemblies, such as DNA 
origami-based nanostructures (2), DNA polyhedra (3), and DNA hydrogel (4-5), have been reported. 
Some of these have been examined as pharmaceuticals or drug delivery systems (1, 6). 
Unmethylated cytosine-phosphate-guanine dinucleotide with appropriate flanking sequences (CpG 
motif) is a pathogen-associated molecular pattern and a ligand for Toll-like receptor 9 (TLR9) 
expressed in various mammalian immune cells (7-9). The binding of DNA containing the CpG motif, 
or CpG DNA, to the receptor leads to the production of proinflammatory cytokines, including tumor 
necrosis factor (TNF)-α, interleukin (IL)-6, and interferon (IFN)-α (10). Therefore, CpG DNA has 
attracted attention in the treatment of cancer, virus infections, and allergic diseases (11-13).  
Apart from the use of chemically stabilized DNA/RNA analogues, such as phosphorothioate DNA 
(14, 15), several attempts have been made to increase the activity of natural phosphodiester CpG 
DNA through efficient delivery of the DNA to the target immune cells. We reported that multi-branched, 
polypod-like structured DNA, or polypodna, prepared using three or more oligodeoxynucleotides 
(ODNs), is a useful DNA nanostructure for the delivery of natural phosphodiester CpG DNA to mouse 
macrophage-like RAW264.7 cells, mouse dendritic DC2.4 cells, mouse bone marrow-derived 
dendritic cells, and human peripheral blood mononuclear cells (16-19). The polypod-like structure was 
found to be quite effective for the delivery of DNA to these immune cells. Separately, Li et al. reported 
that DNA tetrahedron, designed using four ODNs, was useful for the delivery of CpG DNA to 
RAW264.7 cells (20). These previous studies have clearly demonstrated that nanosized DNA 
assemblies are suitable systems for the delivery of CpG DNA to immune cells for immunostimulation. 
However, no systematic studies have been carried out to elucidate the optimal structure of such DNA 
assemblies for the delivery of immunostimulatory CpG DNA to immune cells.  
In this study, we examined the importance of the structure of nanosized DNA assemblies in the 
preparation efficiency as well as the stimulation of immune cells. Since our previous study 
demonstrated that the number and length of ODNs were key parameters for the physicochemical and 
biological properties of polypodnas (18), these parameters were fixed in order to extract the structure-
dependent differences among the nanosized DNA assemblies. To this end, tetrahedral DNA 
(tetrahedron) consisting of four 55-mer ODNs, reported by Li et al. (20), was selected as one of the 
DNA assemblies for comparison. To minimize the difference in the sequences, one of the ODNs for 
the tetrahedron (the common ODN) was used to newly design tetrapodna consisting of four 55-mer 
ODNs. In addition, a tetragonal DNA (tetragon) was also designed with the common ODN and three 
other 55-mer ODNs. These three DNA nanostructures were compared in terms of preparation 
efficiency, physicochemical property, cellular uptake, and immunostimulatory activity. RAW264.7 cells 




MATERIALS AND METHODS 
Chemicals 
Roswell Park Memorial Institute (RPMI) 1640 medium was obtained from Nissui Pharmaceutical, Co., 
Ltd. (Tokyo, Japan). Opti-MEM was purchased from Life Technologies (Rockville, MD, USA). Fetal 
bovine serum (FBS) was obtained from HyClone Laboratories, Inc. (South Logan, UT, USA). The 100 
base pair (bp) DNA ladder was purchased from Takara Bio (Otsu, Japan). All other chemicals were 
the highest grade available and used without further purification. 
 
Cell Culture 
The murine macrophage-like cell line RAW264.7 was cultured in RPMI medium supplemented with 
10% heat-inactivated FBS, 0.2% sodium bicarbonate, 100 IU/mL penicillin, 100 µg/mL streptomycin, 
and 2 mM L-glutamine at 37°C in humidified air containing 5% CO2. RAW264.7 cells were then plated 
on 24-well or 96-well culture plates at a density of 5 × 105 cells/mL and cultured for 24 h prior to use. 
Isolation of Human Peripheral Blood Mononuclear Cells 
All experiments using human primary cells were approved by the institutional review board at the 
Graduate School of Medicine, Kyoto University, and following the tenets of the Declaration of Helsinki. 
Human PBMCs were obtained from healthy donors after obtaining their written informed consent. 
PBMCs were isolated from peripheral blood by density gradient centrifugation using Lympholyte-H 
Cell Separation Media (Cedarlane Laboratories Ltd., Netherlands) as previously reported (21). Cells 
collected were replated on 48-well culture plates at a density of 6 × 105 cells/well in RPMI medium.  
Oligodeoxynucleotides 
All ODNs used were purchased from Integrated DNA Technologies, Inc. (Coralville, IA, USA). The 
sequences of the ODNs used are listed in Table 1. ODN-1 was the common ODN used for all three 
preparations. Each ODN, such as tetrapodna-2, tetrahedron-2, and so on, was identified with the 
name of the DNA assembly and the ODN number. For cellular uptake experiments, ODN-1 labeled 
with Alexa Fluor-488 at the 5′ end (Alexa ODN-1) was purchased from Japan BioService Co., Ltd. 
(Saitama, Japan). CpG ODN-1 was designed in such a way that a 25-base ODN containing a potent 
CpG motif was linked to the 5′-end of the ODN-1, and used for cytokine release experiments. AFM-
tetrapodna-1, AFM-tetrapodna-3, AFM-tetrahedron-2, AFM-tetrahedron-3, AFM-tetragon-2, and AFM-
tetragon-3 were used for AFM imaging. 
Preparation of DNA Nanostructures 
ODNs dissolved in an annealing buffer (TE buffer; 10 mM Tris-HCl, pH 8, 1 mM 
ethylenediaminetetraacetic acid (EDTA), and 50 mM magnesium chloride) were mixed at a final 
concentration of 0.5–20 μM for each ODN. The annealing buffer was used to prepare all the DNA 
samples. The mixtures were then incubated at 95°C for 2 min and slowly cooled down to 4°C using a 
thermal cycler. The annealing condition for tetrahedron was optimized in preliminary experiments, and 
a different condition from the original one (20) was used to minimize the formation of aggregates at 
high DNA concentrations. Each preparation was analyzed at 37°C by the MCE-202 MultiNA microchip 
electrophoresis system for DNA/RNA analysis (Shimadzu, Kyoto, Japan) or by 6% polyacrylamide gel 
electrophoresis. Double-stranded (ds) DNA was prepared by annealing of ODN-1 and ODN-1′.  
Atomic Force Microscopy Imaging of DNA Nanostructures 
Atomic force microscopy (AFM) images were obtained on a high-speed AFM system (Nano Live 
Vision, RIBM, Tsukuba, Japan) using a silicon nitride cantilever (BL-AC10EGS; Olympus, Tokyo, 
Japan) as reported previously (22). All the DNA nanostructures were immobilized to the DNA frame 
using the two long single-stranded sequences on the 5′-end of the two ODNs of each DNA 
nanostructure. In brief, a DNA sample was adsorbed on a freshly cleaved mica plate pretreated with 
0.1% aqueous 3-aminopropyltriethoxysilane for 5 min at room temperature and then washed three 
times with a buffer solution containing 20 mM Tris and 10 mM MgCl2. Scanning was performed in the 
same buffer solution. 
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Measurement of Melting Temperature 
The melting temperatures (Tm) were obtained by measuring the absorbance of tetrapodna, 
tetrahedron, and tetragon in TE buffer containing 50 mM MgCl2 at 260 nm with a Shimadzu UV-1600 
PC spectrometer (Shimadzu, Kyoto, Japan) equipped with a TMSPC-8 temperature controller (23).  
Dynamic Light Scattering Analysis 
The apparent sizes of tetrapodna, tetrahedron, and tetragon were determined by the dynamic light 
scattering method using a Malvern Zetasizer 3000HS (Malvern Instruments, Malvern, UK) at 20°C. 
The measurement was repeated more than eight times, and the results were expressed as the mean 
± SD of the eight measurements. 
Circular Dichroism Spectra of DNA Nanostructures 
The circular dichroism (CD) spectra of DNA were recorded using a JASCO-820 type 
spectropolarimeter (JASCO, Tokyo, Japan) with a 0.1 cm path-length quartz cell at 20°C. The DNA 
samples after annealing were diluted with 50 mM MgCl2-containing TE buffer to a final DNA 
concentration of 68 μg/mL. The CD spectra of DNA were measured in the range of 200 to 320 nm. 
Stability of DNA Nanostructures in 50% FBS 
DNA nanostructures (68 µg/mL) were mixed with non-heat-inactivated FBS of equal volume and 
incubated at 37°C. After 0, 2, 4, 8, 12, or 24 h of incubation, a 10 µL aliquot of the sample solution 
was transferred to plastic tubes and mixed with 20 µL of 0.5 M EDTA solution to stop the degradation, 
and then stored at -20°C until use. These samples were run on 9% polyacrylamide gel 
electrophoresis (PAGE) at 4°C and stained with SYBR Gold (Life Technologies). The density of the 
DNA bands was quantitatively evaluated using the Multi Gauge software (Fujifilm, Tokyo, Japan). 
Cellular Uptake of DNA 
RAW264.7 cells or PBMCs on 96 or 48-well plates at a density of 5 × 104 or 6 × 105 cells/well  were 
incubated with Alexa Fluor 488-labeled single-stranded DNA (ssDNA), tetrapodna, tetrahedron, or 
tetragon diluted in 0.1 mL of Opti-MEM for 2 or 4 h at 37°C. Cells were then washed three times with 
200 or 400 µL of phosphate-buffered saline and harvested. Then, the fluorescent intensity of cells was 
determined by flow cytometry (FACS Calibur or Gallios Flow Cytometer, BD Biosciences, NJ, USA) 
using CellQuest software (version 3.1, BD Biosciences) or Kaluza software (version 1.0, BD 
Biosciences), and the mean fluorescence intensity (MFI) was calculated.  
TNF-α Release from RAW264.7 Cells 
RAW264.7 cells were seeded into 96-well plates at a density of 5 × 104 cells/well. Then, CpG ssDNA, 
CpG tetrapodna, CpG tetrahedron, or CpG tetragon was diluted in 0.1 mL of Opti-MEM and added to 
the cells. The cells were incubated at 37°C for 8 h, and the supernatants were retrieved and stored at 
-80°C until use. The levels of TNF-α in the supernatants were determined by enzyme-linked 
immunosorbent assay (ELISA) using OptEIATM sets (BD Biosciences).  
IFN-α Release from Human PBMCs 
PBMCs were seeded into 48-well plates at a density of 6 × 105 cells/well. Then, CpG ssDNA, CpG 
tetrapodna, CpG tetrahedron, or CpG tetragon was diluted in 0.2 mL of Opti-MEM and added to the 
cells. The cells were incubated at 37°C for 24 h, and the supernatants were retrieved and stored at -
80°C until use. The levels of human IFN-α were determined using the IFN-α–ELISA module set 
(Bender Med Systems, Vienna, Austria). Chloroquine (Sigma-Aldrich, St. Louis, MO, USA) was used 
as a control for TLR involvement PBMCs. Cells were incubated with or without 100 µM chloroquine. 
Statistical Analysis 
Differences were statistically evaluated by one-way analysis of variance (ANOVA) followed by the 




Construction of DNA Nanostructures 
Figure 1 shows the schematic images of tetrapodna, tetrahedron, and tetragon. The blue-colored 
lines indicate the common ODN (ODN-1) for all preparations. Figure 2A shows the MultiNA analysis of 
tetrapodna, tetrahedron, and tetragon prepared at various DNA concentrations (0.5–20 µM). A fixed 
amount of DNA (68 ng) was run on electrophoresis. Tetrapodna had a major single band of around 
140 bp at all the DNA concentrations examined (Figure 2A, lanes 1–5), indicating that tetrapodna was 
successfully formed with high efficiency by simple annealing of ODNs. On the other hand, the band 
for tetrahedron, which was detected around 90 bp, became weaker with increasing DNA 
concentrations at preparation (Figure 2A, lanes 6–10). There were several bands for tetragon 
prepared at high DNA concentrations (Figure 2A, lanes 11–15). The mobility was the fastest for 
tetrahedron, followed by tetrapodna, then tetragon. These differences would be due to the structural 
differences of these DNA nanostructures, as all these DNA nanostructures consisted of 220 
nucleotides. Figure 2B shows the PAGE analysis of these DNA nanostructures prepared at DNA 
concentration of 0.5–20 µM. A significant fraction of tetrahedron remained in the well, suggesting that 
it formed multimers or aggregates under these conditions at high DNA concentrations. The formation 
of tetrapodna, tetrahedron, and tetragon was confirmed using AFM. The PAGE analysis of DNA 
nanostructures for AFM experiments was shown in Supplementary figure 1. A DNA frame prepared 
using the DNA origami method was used to immobilize the DNA nanostructures for imaging. In 
addition, two of the four ODNs for each DNA nanostructure were extended to be immobilized to the 
frame. Figure 3 shows the AFM images of tetrapodna, tetrahedron, and tetragon immobilized to the 
DNA frame. AFM images with large area were shown in Supplementary figure 2. The images clearly 
show that all of the preparations had different structures from one another. Tetrapodna was structured 
with four pods extruding from the center, the structural characteristics of which were almost identical 
to those of a larger tetrapodna consisting of 90-base ODNs (18). The AFM image of tetragon shows a 
rectangular shape as designed. On the other hand, the image for tetrahedron shows a triangular 
structure that was more complicated than the others. 
Tm and Apparent Size of DNA Nanostructures  
The thermal stabilities of tetrapodna, tetrahedron, and tetragon were examined by measuring the Tm. 
Table 2 summarizes the Tm values in TE buffer containing 50 mM magnesium chloride. Tetrapodna 
had the highest Tm, followed by tetragon. The apparent sizes of these DNA nanostructures, 
measured by dynamic light scattering, are also listed in Table 2. All preparations were about 8 nm in 
diameter.  
CD Spectra of DNA Nanostructures 
Figure 4 shows the CD spectra of tetrapodna, tetrahedron, and tetragon. All samples examined had a 
positive peak near 280 nm and a negative peak near 240 nm, and there were no significant 
differences in the spectra. The spectra of the DNA nanostructures were similar to those of dsDNA, 
which exhibited B-form under the conditions examined. 
Stability of DNA Nanostructures in Serum  
Figure 5A shows the PAGE analysis of the DNA nanostructures incubated in solution containing 50% 
non-heat-inactivated FBS. The bands of the DNA nanostructures weakened with time in all cases. In 
addition, the bands shifted down with time because of the degradation of the DNA nanostructures. 
Figure 5B shows the time-courses of the remaining DNA after densitometric analysis of the gels. This 
analysis indicated that tetragon was quickly degraded with time compared with the others. 
Uptake of Alexa Fluor 488-labeled DNA Nanostructures in RAW264.7 Cells 
Figure 6 shows the MFI of RAW264.7 cells after addition of Alexa Fluor 488-labeled DNA samples. 
RAW264.7 cells with added Alexa Fluor 488-labeled tetrahedron showed the highest MFI value, 
followed by Alexa Fluor 488-labeled tetrapodna, tetragon, and ssDNA (ODN-1) in this order. The MFI 
values increased with increasing DNA concentration from 2 to 6 µg/mL in all the cases.  
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TNF-α Release from RAW264.7 Cells after Addition of CpG DNA Nanostructures  
Figure 7A shows the MultiNA analysis of tetrapodna, tetrahedron, and tetragon with an extending 25-
base long sequence containing a CpG motif (Supplementary figure 3 shows the PAGE analysis of 
these DNA nanostructures). Each DNA nanostructure containing CpG DNA was named as CpG 
tetrapodna, CpG tetrahedron, and CpG tetragon, respectively. Figure 7B shows the amount of TNF-α 
released from RAW264.7 cells after addition of CpG ssDNA (CpG ODN-1), CpG tetrapodna, CpG 
tetrahedron, or CpG tetragon. Compared with CpG ssDNA, all of the CpG DNA nanostructures 
induced high amounts of TNF-α. CpG tetrahedron induced the largest amounts of TNF-α, followed by 
CpG tetrapodna. CpG tetragon induced much less TNF-α release from RAW264.7 cells than CpG 
tetrapodna did, even though there were no significant differences in the uptake between Alexa Fluor 
488-labaled tetrapodna and tetragon (Figure 6). Tetrapodna, tetrahedron, or tetragon containing no 
CpG motifs induced little TNF-α release when added to RAW264.7 cells (data not shown). 
DNA Uptake and IFN-α release after Addition of DNA Nanostructures to Human PBMCs  
Figure 8 shows the MFI of human PBMCs after addition of Alexa Fluor 488-labeled DNA samples. 
PBMCs with added Alexa Fluor 488-labeled tetrahedron showed the highest MFI value. The MFI 
values of PBMCs added with either Alexa Fluor 488-labeled ssDNA (ODN-1), tetrapodna, or tetragon 
were comparable to one another. Figure 9 shows the amount of IFN-α released from RAW264.7 cells 
after addition of CpG ssDNA (CpG ODN-1), CpG tetrapodna, CpG tetrahedron, or CpG tetragon in 
the absence or absence of chloroquine. All of the CpG DNA nanostructures induced high amounts of 




The versatility of DNA nanotechnology makes it possible to design DNA nanostructures of any shape 
because the number of ODNs as well as their sequence and length can be arbitrarily selected. This is 
one of the major advantages of DNA nanotechnology, and it was used in the present study to 
construct and compare three different DNA nanostructures. However, a set of ODNs used for a DNA 
nanostructure cannot be used to construct other nanostructures, and a different set of ODNs should 
be prepared for each DNA nanostructure. This difference should be kept in mind when the structural 
properties of DNA nanostructures are compared with one another. In this study, one of the four ODNs 
was used for all the three DNA nanostructures to minimize the differences in the sequence of the 
ODNs. In addition, the GC content, which is a key parameter determining the thermal stability of the 
structures, was adjusted to be comparable among the three DNA nanostructures between 45% and 
47%. Finally, the lack of significant TNF-α release from cells added with any DNA nanostructure 
containing no CpG motifs indicated that TNF-α release after addition of the CpG DNA nanostructures 
could be attributed to the CpG motif. 
 A set of ODNs reported by Li et al. was selected for the comparison because our preliminary 
studies showed that tetrahedron had much lower flexibility in design than tetrapodna. For example, 
tetrahedron was not obtained when four 43-mer ODNs were used (Ohtsuki et al., unpublished results), 
whereas tetrapodna could be formed using four ODNs from 36 to 90-mer ODNs (18). In addition, the 
present study revealed that high ODN concentrations resulted in the formation of multimers or 
aggregates except for tetrapodna, greatly limiting the conditions for preparing the DNA nanostructures 
for comparison, even though preparation efficiency is one of the most important parameters as far as 
biopharmaceutical applications are concerned.  
 Structures other than those examined in this study can also be designed using four 55-mer 
ODNs. A simpler structure is a linear one partly or fully containing double-stranded DNA. The 
structural properties of such linear DNA would be similar to those of double-stranded DNA, and 
therefore, it was not included for comparison in this study. Other structures would share the structural 
properties with either tetrapodna (branched DNA), tetrahedron (three-dimensional DNA), or tetragon 
(rectangular or circular DNA), as far as symmetric structures are concerned. Therefore, the three DNA 
nanostructures would be reasonable for comparing the structural and biological properties of DNA 
nanostructures that were designable using four short ODNs. 
 The present study clearly demonstrated that tetrapodna was far the best DNA nanostructure 
in terms of both the preparation efficiency and biological activity. This would be, at least in part, 
attributed to its high thermal stability (Table 2). The lengths of the consecutive double-stranded parts 
in each structure were 27, 17, and 26 for tetrapodna, tetrahedron, and tetragon, respectively, and the 
long double-stranded parts could explain the high Tm value of tetrapodna. The Tm values of the 
incomplete structures consisting of three out of four ODNs were 73°C, 68°C, and 71°C for tetrapodna, 
tetrahedron, and tetragon, respectively. In addition, the Tm values of the 27-mer double-stranded 
DNA identical to a branch of tetrapodna and 26-mer double-stranded DNA identical to a side of 
tetragon were 72°C and 70°C, respectively. These results strongly indicated that the complete 
structure of tetrapodna was more thermally stable than the incomplete ones. This unique property is a 
reason for the very high preparation efficiency of tetrapodna, even at high DNA concentrations. In 
contrast, the others were not stabilized by the formation of complete structures, which led to the 
formation of multimers/aggregates at high DNA concentrations. 
 The above discussions on the thermal stability suggested that it is difficult to re-design 
tetrahedron with high preparation efficiency even at high DNA concentrations. Li et al. reported that 
tetrahedron could be obtained by self-assembly of four ODNs, but the authors prepared tetrahedron 
at a low DNA concentration of 1 µM (20). As demonstrated in the present study, increasing the DNA 
concentration reduced the preparation efficiency of tetrahedron. Any approach to avoid the 
oligomerization of tetrahedron would greatly expand its usefulness as delivery vehicles to immune 
cells. 
 DNA nanostructures, including tetrahedron, were considered to be monomer under the 
experimental conditions examined, but the possibility that they form multimers or aggregates at their 
interaction with cells cannot be excluded at this moment. Therefore, there is still a possibility that the 
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efficient cellular uptake of tetrahedron is due to its more efficient formation of multimers or aggregates 
than the others. 
 Our previous study on the interaction of polypodnas with immune cells, including RAW264.7 
cells and mouse bone marrow-derived dendritic cells, indicated that DNA assemblies with bulky 
structures were more efficiently taken up by the cells compared with ones with sparse structures (16-
19). A previous study reported that longer DNA was better than short ones in terms of cellular uptake 
(18). Several receptors or membrane proteins have been reported to be involved in the cellular uptake 
of DNA (24, 25), although no consensus applicable to various cells has been reached yet. However, 
the results of the cellular uptake of DNA preparations suggested that the interaction of DNA with the 
cell surface at multiple sites facilitated its cellular uptake. The present study showed that tetrahedron 
was better than tetrapodna in terms of the uptake by RAW264.7 cells (Figure 6). The formation of 
oligomers might be involved in the efficient uptake of tetrahedron, even though tetrahedron was 
prepared under conditions where multimers were not easily formed (Figure 2A, lane 9). The reason 
for this efficient cellular uptake of tetrahedron requires further investigation. 
 The experimental results obtained with human PBMCs showed large variations compared to 
those with RAW264.7 cells, probably because of intraindividual and/or interindividual variability in the 
property of the cells. Generally speaking, however, the results were comparable to those with 
RAW264.7 cells, suggesting that the DNA nanostructures examined in this study, especially CpG 
tetrapodna and CpG tetrahedron, induce cytokines, including IFN-α, in humans more efficiently than 
CpG ssDNA. The substantial inhibition of IFN-α release from human PBMCs by chloroquine, an 
inhibitor of endosomal TLR signaling, strongly suggests that the TLR9 is involved in the IFN-α release 
from the cells after addition of CpG tetrapodna, CpG tetrahedron or CpG tetragon. In contrast, the 
uptake of Alexa Fluor488-labeled tetrapodna and tetragon by human PBMCs was comparable to that 
of Alexa Fluor488-labeled ssDNA, which was different from the results obtained using RAW264.7 
cells (Fig. 8), A possible explanation on this difference is that the population of cells that can be 
responsible for stimulation with CpG DNA in PBMCs, i.e., plasmacytoid dendritic cells, is quite low 
(26). A higher uptake of Alexa Fluor488-labeled tetrahedron than the others may indicate that 
tetrahedron is efficiently taken up not only by plasmacytoid dendritic cells but by other cells in PBMCs. 
 The present study clearly showed that tetrapodna had the highest thermal stability, best 
formation efficiency, and CpG tetrapodna possessed high potency to induce TNF-α release from 
RAW264.7 cells and IFN-α release from PBMCs. Despite efficient cellular uptake and TNF-α release, 
the low formation efficiency of tetrahedron greatly limited its application as a delivery vehicle of 
immunostimulatory DNAs. CpG tetragon was the least efficient in terms of TNF-α release. Taken 
together, we conclude that tetrapodna is the best assembly as delivery vehicles for 
immunostimulatory nucleic acids to immune cells, and that tetrahedron can be another useful 
assembly for cellular delivery if its preparation yield is improved. 
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FIGURE LEGENDS  
Figure 1. Schematic presentation of tetrapodna, tetrahedron, and tetragon. The blue-colored arrows 
are the common ODN (ODN1). The arrowheads represent the 3′-end of each ODN. 
Figure 2. Electrophoretic analysis of tetrapodna, tetrahedron, and tetragon. (A) Aliquots of tetrapodna, 
tetrahedron, and tetragon (68 ng) prepared at 0.5–20 µM DNA were run on a MultiNA microchip 
electrophoresis system. Lanes 1–5, tetrapodna (20, 10, 5, 1, and 0.5 µM); lanes 6–10, tetrahedron 
(20, 10, 5, 1, and 0.5 µM); lanes 11–15, tetragon (20, 10, 5, 1, and 0.5 µM); lane 16, 100-bp DNA 
ladder. (B) Aliquots of tetrapodna, tetrahedron, and tetragon (68 ng) prepared at 0.5–20 µM DNA 
were run on a PAGE. Lanes 1, 7, and 13, 100-bp ladder, lanes 2–6, tetrapodna (20, 10, 5, 1, and 0.5 
µM); lanes 8–12, tetrahedron (20, 10, 5, 1, and 0.5 µM); lanes 14–18, tetragon (20, 10, 5, 1, and 0.5 
µM). 
Figure 3. AFM images of tetrapodna, tetrahedron, and tetragon. The white rectangles with a window 
represent DNA origami frames. All DNA samples were annealed at a DNA concentration of 1 µM to 
exclude the higher structures/aggregates of tetrahedron. The white bars indicate 20 nm.  
Figure 4. CD spectra of tetrapodna, tetrahedron, and tetragon. CD spectra were recorded using a 
JASCO-820 type spectropolarimeter. To facilitate comparisons, the background of CD spectra was 
subtracted. 
Figure 5. Degradation of tetrapodna, tetrahedron, and tetragon in 50% non-heat-inactivated FBS. (A) 
Each sample incubated at 37°C for indicated times was run on 9% polyacrylamide gel and stained 
with SYBR Gold. PAGE results are representative of five independent experiments. (B) The density of 
full-length DNA bands was quantitatively evaluated using the Multi Gauge software. The remaining 
amounts of full-length DNA were plotted against the incubation time. Results are expressed as mean 
+ SEM of five independent experiments.  
Figure 6. Uptake of ssDNA (ODN-1), tetrapodna, tetrahedron, and tetragon in RAW264.7 cells. Each 
Alexa Fluor 488-labeld DNA sample was added to cells at a final concentration of 2 or 6 µg/mL. Non-
labeled ODNs were added to Alexa Fluor 488-labeld ssDNA to adjust the amount of the fluorescently 
labeled DNA added to the cells. The MFI of RAW264.7 cells was measured as an index of cellular 
uptake (n = 4 per group). Results are expressed as mean + SEM of three independent experiments. 
*P < 0.05 compared with ssDNA at the same concentration. 
Figure 7. Preparation of CpG tetrapodna, CpG tetrahedron, and CpG tetragon and TNF-α release 
after addition of CpG DNAs to RAW264.7 cells. (A) Aliquots of tetrapodna, tetrahedron, and tetragon 
with (75 ng) or without CpG DNA (68 ng) prepared at 1 µM DNA were run on a MultiNA microchip 
electrophoresis system. Lane 1, tetrapodna; lane 2, tetrahedron; lane 3, tetragon; lane 4, CpG 
tetrapodna; lane 5, CpG tetrahedron; lane6, CpG tetragon; lane 7, 100-bp DNA ladder. (B) Each DNA 
sample was added to cells at a final concentration of 2 or 6 µg/mL, and the concentrations of TNF-α in 
the supernatant were measured at 8 h (n = 4 per group). Non-CpG ODNs were added to CpG ssDNA 
to adjust the amount of the CpG DNA added to the cells. Results are expressed as mean + SEM of 
four independent experiments. *P < 0.05 compared with ssDNA at same concentration. 
Figure 8. Uptake of ssDNA (ODN-1), tetrapodna, tetrahedron, and tetragon in human PBMCs. Each 
Alexa Fluor 488-labeld DNA sample was added to cells at a final concentration of 6 µg/mL. Non-
labeled ODNs were added to Alexa Fluor 488-labeld ssDNA to adjust the amount of the fluorescently 
labeled DNA added to the cells. The MFI of PBMCs was measured as an index of cellular uptake (n = 
4 per group). Each symbol represents a mean of a single experiment, and each experiment is 
identified with different symbols. Bars represent the mean of four independent experiments. *P < 0.05 
compared with ssDNA. 
Figure 9. IFN-α release after addition of CpG DNAs to human PBMCs with or without treatment with 
100 µM chloroquine. Each DNA sample was added to cells at a final concentration of 6 µg/mL, and 
the concentrations of IFN-α in the supernatant were measured at 24 h (n = 4 per group). Non-CpG 
ODNs were added to CpG ssDNA to adjust the amount of the CpG DNA added to the cells. Each 
symbol represents a mean of a single experiment, and each experiment is identified with different 
symbols. Bars represent the mean of three independent experiments. 
Supplementary Figure 1. Electrophoretic analysis of tetrapodna, tetrahedron, and tetragon for AFM. 
Aliquots of tetrapodna, tetrahedron, and tetragon for AFM prepared at 1 µM DNA were run on a 
PAGE. Lane 1, 100-bp ladder; lane 2, tetrapodna; lane 3, tetrahedron; lane 4, tetragon. 
Supplementary Figure 2. AFM images of tetrapodna, tetrahedron, and tetragon. The white rectangles 
with a window represent DNA origami frames. 
Supplementary Figure 3. Electrophoretic analysis of CpG tetrapodna, CpG tetrahedron, and CpG 
tetragon. Aliquots of CpG tetrapodna, CpG tetrahedron, and CpG tetragon (68 ng) prepared at 1 µM 
DNA were run on a PAGE. Lane 1, 100-bp ladder; lane 2, CpG tetrapodna; lane 3, CpG tetrahedron; 
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TABLES 
Table 1. The sequences of ODNs for DNA nanostructures 




























































All ODNs have a phosphodiester backbone. The asterisk (*) indicates the position of Alexa Fluor-488 
modification. Underlined is the CpG motif (GACGTT).  
Table 2. Tm and apparent size of tetrapodna, tetrahedron, and tetragon 
DNA Tm (°C) Size (nm) 
Tetrapodna 77.4 7.4 ± 0.8 
Tetrahedron 68.3 8.5 ± 0.9 
Tetragon 73.0 8.4 ± 1.0 
 
 
 
